uniQure N.V. is a gene therapy company based in Amsterdam, the Netherlands. It develops treatments that use modified viruses to deliver working genes into patients' cells, focusing on rare and severe genetic diseases. Its main programme is a gene therapy for hemophilia B, and it also works on therapies for other disorders affecting the nervous system and metabolic conditions. Its customers are mainly healthcare providers and patients treated through specialist centres, while it partners with larger pharmaceutical companies on development and manufacturing.
The shares are listed on the London Stock Exchange in UK under the code 0EE0, and the price on this page is in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3051 of 3788 on the London Stock Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
39/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-20.8%
From 52-week high-53.3%
MomentumWeak
46/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-39.1%
6-month return30.8%
Stability (higher is calmer)Weak
7/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)126.8%
Worst drawdown, 1 year (smaller is calmer)-66.1%
LiquidityWeak
33/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.14M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 7.50 – 53.00Daily closes, split-adjusted
Signals
50-day average35.82
200-day average29.79
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.93
Technical summary
Daily
Bearish
4 bullish · 2 neutral · 9 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 6 bearish
Monthly
Strongly bearish
0 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
22.21
Bullish
EMA 10
22.75
Bullish
SMA 20
22.47
Bullish
EMA 20
24.96
Bearish
SMA 50
35.82
Bearish
EMA 50
31.38
Bearish
SMA 100
38.71
Bearish
EMA 100
33.54
Bearish
SMA 200
29.79
Bearish
EMA 200
–
n/a
Oscillators (daily)
RSI (14)
36.76
Neutral
MACD (12, 26)
-3.60
Bearish
Momentum (12)
5.82
Bullish
Stochastic %K (14)
82.17
Bearish
Williams %R (14)
-17.83
Bearish
CCI (20)
45.47
Neutral
Pivot points (classic, last session)
S3
19.96
S2
20.78
S1
22.20
Pivot
23.02
R1
24.44
R2
25.26
R3
26.68
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
